Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracardiac thrombus formations despite continuous oral anticoagulation in atrial fibrillation patients undergoing catheter ablation procedures: pilot development of a machine learning prediction model.

Frontiers in cardiovascular medicine·2026
Same author

State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Statistical Combination of ATLAS Run 2 Searches for Charginos and Neutralinos at the LHC.

Physical review letters·2024
Same author

Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.

Physical review letters·2024
Same author

Combination of Searches for Resonant Higgs Boson Pair Production Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2024
Same author

Search for Nearly Mass-Degenerate Higgsinos Using Low-Momentum Mildly Displaced Tracks in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2024
Same journal

[Extrasystoles in endurance athletes].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[AI-Assisted ECG diagnostics : Classical test statistics still apply].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Perioperative complications during transvenous pacemaker and defibrillator implantation].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Late complications after atrial fibrillation ablation : Diagnosis and management].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary].

Herzschrittmachertherapie & Elektrophysiologie·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

Published on: September 23, 2018

[Remote control in ICD therapy].

P Sommer1, G Hindricks, C Piorkowski

  • 1Abt. für Rhythmologie, Universität Leipzig - Herzzentrum, Strümpellstr. 39, 04289, Leipzig, Deutschland. philipp.sommer@herzzentrum-leipzig.de

Herzschrittmachertherapie & Elektrophysiologie
|May 28, 2010
PubMed
Summary
This summary is machine-generated.

This review examines how remote monitoring of implantable cardioverter-defibrillators (ICDs) helps manage patients with heart rhythm issues, potentially reducing the need for frequent in-person clinic visits while improving care efficiency.

Keywords:
cardiac rhythm managementtelemedicineheart failure caredevice interrogation

Frequently Asked Questions

More Related Videos

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
11:24

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy

Published on: October 18, 2011

Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain
06:13

Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain

Published on: March 1, 2024

Related Experiment Videos

Last Updated: Jun 12, 2026

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
14:56

The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb

Published on: September 23, 2018

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
11:24

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy

Published on: October 18, 2011

Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain
06:13

Using Home-based, Remotely Supervised, Transcranial Direct Current Stimulation for Phantom Limb Pain

Published on: March 1, 2024

Area of Science:

  • Cardiovascular medicine and ICD therapy outcomes
  • Digital health and remote monitoring technologies

Background:

No prior work had resolved the logistical strain caused by the rising volume of patients requiring regular device checks. Clinical practice currently demands at least two annual in-person evaluations for individuals with implanted cardiac devices. This requirement creates a significant burden on medical staff and increases travel demands for patients. Prior research has shown that traditional follow-up schedules struggle to keep pace with growing implantation rates. That uncertainty drove the need for alternative strategies to manage these complex patient populations. The current standard of care faces challenges regarding the timely detection of device malfunctions or clinical deterioration. Researchers have sought ways to bridge the gap between physical clinic visits and continuous patient oversight. This context highlights the necessity of evaluating digital transmission methods to optimize existing cardiac care workflows.

Purpose Of The Study:

The aim of this review is to evaluate the effectiveness of remote monitoring as a strategy for managing patients with implantable cardioverter-defibrillators. This study addresses the challenges posed by the rising number of device implantations globally. The authors seek to determine if digital data transmission can replace the traditional, labor-intensive requirement for frequent in-office visits. This investigation explores how such technology impacts the time delay between the detection of device issues and clinical action. The researchers also examine the potential for these systems to reduce travel costs and logistical burdens for patients. The study highlights the necessity of identifying whether remote interrogations offer diagnostic advantages beyond standard device follow-up. This work aims to clarify if these tools allow for more complex management of the heart failure population. The motivation stems from the need to optimize care pathways in the face of increasing clinical demand.

Main Methods:

The review approach involved synthesizing evidence from multiple studies evaluating digital data transmission for cardiac implants. Investigators examined the impact of these systems on clinical workflows and patient-related logistical requirements. The analysis focused on comparing traditional in-office visit frequencies with modern tele-monitoring capabilities. Researchers assessed the safety profiles reported across various clinical trials regarding these electronic devices. The methodology prioritized data concerning the reduction of follow-up burdens for both medical providers and patients. Experts reviewed findings related to the time intervals between the onset of device issues and professional responses. This evaluation framework also considered the potential for expanded diagnostic utility within the heart failure population. The synthesis relied on existing literature to characterize the current landscape of cardiac device management.

Main Results:

Key findings from the literature indicate that remote follow-up is a safe method for managing patients with cardiac implants. The evidence demonstrates that this approach effectively reduces the resource requirements for both physicians and patients. Studies show that digital transmission helps minimize the time delay between the occurrence of medical problems and adequate clinical responses. The literature highlights that this technology successfully addresses the growing demand for frequent in-office interrogations. Researchers report that these systems alleviate the travel burden previously placed on individuals requiring device checks. The data suggest that remote oversight maintains high standards of patient safety while improving overall care efficiency. Findings confirm that this strategy is a viable alternative to the traditional twice-yearly in-office visit schedule. The literature underscores the potential for these systems to support the management of large heart failure patient cohorts.

Conclusions:

The authors propose that remote monitoring serves as a safe alternative to conventional in-person follow-up protocols. Evidence suggests this strategy successfully lowers the resource utilization for both clinical teams and those receiving treatment. Experts indicate that these systems potentially decrease the interval between the emergence of clinical issues and medical intervention. Future investigations must determine if these platforms provide diagnostic capabilities exceeding standard device checks. The researchers suggest that such advancements could facilitate more sophisticated management of heart failure patients. This synthesis implies that digital oversight might transform the standard care pathway for individuals with cardiac implants. The findings support the integration of remote data transmission to alleviate the logistical pressures on modern cardiology practices. These conclusions emphasize the potential for improved efficiency without compromising the safety of the patient population.

The researchers propose that remote monitoring enhances care by decreasing the time between the appearance of medical complications and the subsequent physician intervention, while simultaneously lowering the frequency of mandatory in-office checkups.

The authors identify that remote transmission systems act as the core tool, allowing for the off-site relay of device-specific data to medical professionals, thereby bypassing the need for physical presence.

The authors state that in-person interrogations are currently required at least twice annually to ensure device integrity and patient safety, necessitating a shift toward more efficient monitoring solutions.

The researchers utilize data derived from device transmissions to evaluate the safety and efficacy of remote follow-up, comparing these digital metrics against traditional, manual clinic-based assessment outcomes.

The authors note that the reduction in travel costs for patients and the decrease in follow-up burden for physicians serve as key metrics for measuring the success of remote oversight.

The researchers suggest that remote interrogation might eventually allow for more complex management of heart failure patients, potentially offering diagnostic options that extend beyond basic device status checks.